# A Trial Study of SGN-00101 in Treating Pediatric Patients With Recurrent Respiratory Papillomatosis

> **NCT00038714** · PHASE2 · COMPLETED · sponsor: **Nventa Biopharmaceuticals Corporation** · enrollment: 27 (estimated)

## Conditions studied

- Papilloma
- Recurrent Respiratory Papillomatosis

## Interventions

- **DRUG:** SGN-00101

## Key facts

- **NCT ID:** NCT00038714
- **Lead sponsor:** Nventa Biopharmaceuticals Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-11
- **Primary completion:** —
- **Final completion:** 2004-01
- **Target enrollment:** 27 (ESTIMATED)
- **Last updated:** 2007-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00038714

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00038714, "A Trial Study of SGN-00101 in Treating Pediatric Patients With Recurrent Respiratory Papillomatosis". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00038714. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*